Tomas Konecny
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tomas Konecny has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Marek Orban
Comenius University and NUSCH, Bratislava, Slovakia
5 shared publicationsPeter A. Brady
Mayo Clinic, Rochester, Minnesota
4 shared publicationsJae Yoon Park
Mayo Clinic, Rochester, MN, United States of America
3 shared publicationsCharanjit S. Rihal
University of Southern California, Los Angeles, California
2 shared publicationsHiroko Beck‐Fernandez
University of Florida, College of Medicine
2 shared publicationsKiran R. Somers
University of Southern California, Los Angeles, California
2 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (12) , e047053
Survival With β‐Adrenergic Suppression After Lung Transplantation
Background: Survival following lung transplant (LT) surgery presents an ongoing challenge, and adverse LT outcomes are linked to cardiac arrhythmias. Current guidelines indicate that the role of β‐adrenergic suppression (BAS) after LT remains unclear. Methods: This retrospective observational study included adult patients who underwent LT at the University of Florida between 2016 and 2021. Their pre‐ and post‐LT antiarrhythmic medication use was correlated with long‐term survival after a 10‐day post‐LT blanking window. Results: The LT recipients (N=299) had a mean age of 60±11 years, 45% were women, and mean body mass index was 26±6 kg/m 2 . Available mean follow‐up was 4.5±1.9 years. The primary analysis included 299 patients, of whom 209 (70%) were prescribed BAS. Prescription of BAS after LT correlated with prolonged survival, even after adjusting for potential confounders ( P =0.008). A comparable survival benefit was observed in patients who continued BAS from pre‐LT to those who were newly initiated on BAS after LT, relative to patients not receiving BAS ( P =0.03 and P =0.03, respectively). No survival benefit was observed for other classes of antiarrhythmic drugs used after LT. Conclusions: This large, retrospective, single‐center study identified a correlation between BAS prescriptions and prolonged survival following LT. This association applied to both patients initiating BAS after transplant and those continuing preexisting BAS therapy. These findings underscore the promise of BAS in this population, and further prospective studies are warranted to confirm the beneficial role of BAS after LT.
- 16 June 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (12) , e047053
Open AccessSurvival With β‐Adrenergic Suppression After Lung Transplantation
Background: Survival following lung transplant (LT) surgery presents an ongoing challenge, and adverse LT outcomes are linked to cardiac arrhythmias. Current guidelines indicate that the role of β‐adrenergic suppression (BAS) after LT remains unclear. Methods: This retrospective observational study included adult patients who underwent LT at the University of Florida between 2016 and 2021. Their pre‐ and post‐LT antiarrhythmic medication use was correlated with long‐term survival after a 10‐day post‐LT blanking window. Results: The LT recipients (N=299) had a mean age of 60±11 years, 45% were women, and mean body mass index was 26±6 kg/m 2 . Available mean follow‐up was 4.5±1.9 years. The primary analysis included 299 patients, of whom 209 (70%) were prescribed BAS. Prescription of BAS after LT correlated with prolonged survival, even after adjusting for potential confounders ( P =0.008). A comparable survival benefit was observed in patients who continued BAS from pre‐LT to those who were newly initiated on BAS after LT, relative to patients not receiving BAS ( P =0.03 and P =0.03, respectively). No survival benefit was observed for other classes of antiarrhythmic drugs used after LT. Conclusions: This large, retrospective, single‐center study identified a correlation between BAS prescriptions and prolonged survival following LT. This association applied to both patients initiating BAS after transplant and those continuing preexisting BAS therapy. These findings underscore the promise of BAS in this population, and further prospective studies are warranted to confirm the beneficial role of BAS after LT.
- Open Access
- 20 May 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (10) , e041947
Why Is Sleep Apnea Treatment Success Driven by Patient Choice, Not Randomization?
- 20 May 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (10) , e041947
Open AccessWhy Is Sleep Apnea Treatment Success Driven by Patient Choice, Not Randomization?
- 1 January 2021
- Published by Elsevier in International Journal of Cardiology
- Vol. 323, 155-160
Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy
- 1 January 2021
- Published by Elsevier in International Journal of Cardiology
- Vol. 323, 155-160
Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy
- 1 June 2019
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 5 (6) , 702-704
Things We Have Always Wanted to Know About Sleep Apnea and Atrial Fibrillation (But Were Afraid to Ask)
- 1 June 2019
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 5 (6) , 702-704
Things We Have Always Wanted to Know About Sleep Apnea and Atrial Fibrillation (But Were Afraid to Ask)
- 1 November 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 122 (9) , 1482-1488
Usefulness of Heart Rate Control in Atrial Fibrillation Patients With Obstructive Sleep Apnea
- 1 November 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 122 (9) , 1482-1488
Usefulness of Heart Rate Control in Atrial Fibrillation Patients With Obstructive Sleep Apnea
- 1 June 2018
- Published by Elsevier in Heart Rhythm
- Vol. 15 (6) , 832-838
Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular function
- 1 June 2018
- Published by Elsevier in Heart Rhythm
- Vol. 15 (6) , 832-838
Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular function
- 14 December 2016
- Published by SAGE Publications in Perfusion
- Vol. 32 (4) , 279-284
Impact of cardiopulmonary bypass surgery on cytokines in epicardial adipose tissue: comparison with subcutaneous fat
Background: Cardiac surgery and cardiopulmonary bypass (CPB) have been shown to stimulate a systemic inflammatory response which has been associated with adverse postoperative outcomes. Adipose tissue, both epicardial (EAT) and subcutaneous (SAT), is a known source of inflammatory cytokines, but its role in the pathophysiology of surgery- and CPB-induced systemic inflammatory response has not been fully elucidated. Therefore, we conducted a study to establish levels of selected cytokines in EAT and SAT prior to and after surgery with CPB. Methods: Adipose tissue samples were obtained from patients undergoing planned cardiac surgery on CPB. Samples from EAT and SAT were collected before and immediately after CPB. Levels of tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), adipocyte fatty acid-binding protein (AFABP), leptin and adiponectin were determined by ELISA, which were adjusted for a total concentration of proteins in the individual samples. Results: Samples from 77 patients (mean age 67.68 ± 11.5 years) were obtained and analysed. Leptin, adiponectin, TNF-α and AFABP were shown to decrease their concentrations statistically significantly in the EAT after CPB while no statistically significant drop was observed in the SAT. On the contrary, IL-6 showed only a slight and statistically insignificant decrease in the EAT after CPB and it was in the SAT where a statistically significant drop was observed. Discussion: One of the most relevant findings of this study was the marked decrease in EAT levels of TNF-α, AFABP, leptin and adiponectin after the CPB termination. Our results suggest that EAT might serve as a pool of cytokines which are released into the circulation in reaction to surgery with CPB. Should these novel findings be confirmed, new strategies to assess and possibly reduce EAT contribution on adverse outcomes of cardiac surgery may be developed.
- 14 December 2016
- Published by SAGE Publications in Perfusion
- Vol. 32 (4) , 279-284
Impact of cardiopulmonary bypass surgery on cytokines in epicardial adipose tissue: comparison with subcutaneous fat
Background: Cardiac surgery and cardiopulmonary bypass (CPB) have been shown to stimulate a systemic inflammatory response which has been associated with adverse postoperative outcomes. Adipose tissue, both epicardial (EAT) and subcutaneous (SAT), is a known source of inflammatory cytokines, but its role in the pathophysiology of surgery- and CPB-induced systemic inflammatory response has not been fully elucidated. Therefore, we conducted a study to establish levels of selected cytokines in EAT and SAT prior to and after surgery with CPB. Methods: Adipose tissue samples were obtained from patients undergoing planned cardiac surgery on CPB. Samples from EAT and SAT were collected before and immediately after CPB. Levels of tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), adipocyte fatty acid-binding protein (AFABP), leptin and adiponectin were determined by ELISA, which were adjusted for a total concentration of proteins in the individual samples. Results: Samples from 77 patients (mean age 67.68 ± 11.5 years) were obtained and analysed. Leptin, adiponectin, TNF-α and AFABP were shown to decrease their concentrations statistically significantly in the EAT after CPB while no statistically significant drop was observed in the SAT. On the contrary, IL-6 showed only a slight and statistically insignificant decrease in the EAT after CPB and it was in the SAT where a statistically significant drop was observed. Discussion: One of the most relevant findings of this study was the marked decrease in EAT levels of TNF-α, AFABP, leptin and adiponectin after the CPB termination. Our results suggest that EAT might serve as a pool of cytokines which are released into the circulation in reaction to surgery with CPB. Should these novel findings be confirmed, new strategies to assess and possibly reduce EAT contribution on adverse outcomes of cardiac surgery may be developed.
- 1 April 2015
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 8 (2) , 508-511
Percutaneous Transapical Access With Closure for Ventricular Tachycardia Ablation
- 1 April 2015
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 8 (2) , 508-511
Percutaneous Transapical Access With Closure for Ventricular Tachycardia Ablation